Request for Information - Reagents

Request for Information/Sources Sought

Defense Logistics Agency - Troop Support – Europe & Africa (DLA - TS E&A) Indefinite Delivery/Indefinite Quantity (IDIQ) Contract for Laboratory Reagents, Test Kits, and Consumables Supporting USAMMCE and OCONUS Customers

Notice Type
Sources Sought / Request for Information (RFI)
Product Service Code (PSC)
6550 – In Vitro Diagnostic Substances, Reagents, Test Kits and Sets NAICS Code
325413 – In-Vitro Diagnostic Substance Manufacturing (or 423450 – Medical, Dental, and Hospital Equipment Merchant Wholesalers) Contract Vehicle Type
Commercial Item (FAR Part 12) / Indefinite Delivery/Indefinite Quantity (IDIQ) Primary Delivery Location
U.S. Army Medical Materiel Center-Europe (USAMMCE), Kaiserslautern, Germany Anticipated Ordering Period
Five (5) Year Ordering Period (15 January 2028 – 14 January 2033)

1. Disclaimer & Purpose of Notice

This is a Request for Information (RFI) / Sources Sought Notice issued for Market Research and planning purposes only. This is not a Request for Proposal (RFP), solicitation, or promise to issue an award. The Government will not pay for any information or administrative costs incurred in responding to this RFI. All costs associated with responding are solely at the respondent’s expense. Responses will not be returned and will be treated as information to shape the Government's acquisition strategy.

2. Requirement Overview

DLA – TS E&A, in conjunction with the United States Army Medical Materiel Center-Europe (USAMMCE), is conducting market research to support the recompete of its commercial laboratory supplies contract. The resulting contract will provide clinical laboratory reagents, test cartridges, calibrators, controls, and associated consumables that operate in conjunction with specific Government-owned laboratory analyzers and capital equipment (e.g., Abbott i-STAT, Siemens DCA 2000, and other point-of-care or automated platforms). The primary ordering activity and logistics hub is USAMMCE, servicing Department of Defense (DoD) medical treatment facilities and operational forces across the European Command (EUCOM) and possibly Central Command (CENTCOM) theaters. The follow-on ordering period is projected to commence on 15 January 2028.

3. Industry Feedback & Inquiry Areas

The Government requests that interested vendors provide comprehensive feedback on the following two (2) areas: A: Draft Statement of Work (SOW) Review
Vendors are requested to thoroughly review the attached draft SOW and submit any questions and/or comments from your analysis. To ensure effective evaluation, respondents MUST cite the specific SOW Page Number, Section, and Paragraph Number for each individual comment or question. The draft SOW contains specific language highlighted in yellow, denoting updates or new terms compared to the current contracts. The Government specifically requests industry's assessment of these highlighted provisions regarding feasibility, commercial alignment, and potential cost drivers.